Table 2.
Median age | 49 / (21–63) |
Female | 3 (21%) |
Male | 11 (79%) |
IDH-1/2 wild-type | 12/14 (86%) |
Unmethylated MGMT promoter | 10/14 (71%) |
Response | |
Complete response (CR) | 6 (43%) |
Partial response (PR) | 6 (43%) |
Stable disease (SD) | 0 (0%) |
Progressive disease (PD) | 2 (14%) |